Status | Study |
Recruiting |
Study Name: Reduced Intensity Conditioning in Patients Aged ≤35 With Non-Malignant Disorders Undergoing UCBT, BMT, or PBSCT Condition: Primary Immunodeficiency Syndromes Congenital Bone Marrow Failure Syndromes Date: 2013-10-10 Interventions: Drug: Hydroxyurea Hydroxyurea |
Recruiting |
Study Name: BMT Abatacept for Non-Malignant Diseases Condition: Hurler Syndrome Fanconi Anemia Glanzmann Thrombasthenia Date: 2013-07-24 Interventions: Drug: Abatacept All patients will receive 4 doses of abatacept in addition to standard GVHD prophylaxis |
Recruiting |
Study Name: Immune Disorder HSCT Protocol Condition: Immune Deficiency Disorders Severe Combined Immunodeficiency Date: 2013-03-19 Interventions: Drug: Transplant preparative regimen of alemtuzumab, fludarabine, thiotepa, and melphalan Between days - |
Recruiting |
Study Name: Allogeneic Hematopoietic Stem Cell Transplant for Patients With Primary Immune Deficiencies Condition: SCID Omenn's Syndrome Reticular Dysgenesis Date: 2012-07-25 Interventions: Drug: Alemtuzumab 0.3 mg 0.3 m |
Suspended |
Study Name: Alefacept and Allogeneic Hematopoietic Stem Cell Transplantation Condition: Thalassemia Sickle Cell Disease Glanzmann Thrombasthenia Date: 2010-09-15 Interventions: Drug: Alefacept 0.25 mg/kg IV on day -40 and day -39 0.5 mg/kg IV on days -33, -26, -19 and -12 Alefacep |
Completed |
Study Name: Unrelated Hematopoietic Stem Cell Transplantation(HSCT) for Genetic Diseases of Blood Cells Condition: Sickle Cell Disease Thalassemia Anemia Date: 2008-08-06 Interventions: Procedure: Hematopoietic stem cell transplantation hematopoietic stem cell transplantation conditioning |
Completed |
Study Name: Stem Cell Transplant for Immunologic or Histiocytic Disorders Condition: Hemophagocytic Lymphohistiocytosis X-Linked Lymphoproliferative Disorders Date: 2005-09-12 Interventions: Procedure: Stem Cell Transplant |
Completed |
Study Name: T-Cell Depletion and Stem Cell Transplant for Immune Deficiencies and Histiocytic Disorders Condition: Hemophagocytic Lymphohistiocytosis X-Linked Lymphoproliferative Disorders Date: 2005-09-12 Interventions: Procedure: Stem Cell Transplant |
Completed |
Study Name: Study of Megakaryocytes From Patients With Abnormal Platelet Vesicles Condition: Blood Coagulation Disorders Date: 2004-07-01 |
Completed |
Study Name: Pilot Study of Unrelated Donor Hematopoietic Stem Cell Transplantation in Patients With Life Threatening Hemophagocytic Disorders Condition: Chediak-Higashi Syndrome Graft Versus Host Disease Date: 2000-07-05 Interventions: Drug: anti-thymocyte globulin Drug: busulf |